Loading company…
Tavros Therapeutics discovers cancer drug targets and develops small-molecule therapies.
Founded in 2019, Tavros Therapeutics is based in Durham, US, and uses functional and computational genomics to identify tumor vulnerabilities and develop cancer treatments. Its platform maps synthetic lethal relationships to build a pipeline of small-molecule candidates. In September 2022, it raised USD 7.5 million in seed funding co-led by KdT Ventures and Piedmont Capital Partners, with participation from Alexandria Venture Investments.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in